Cooper Cos. (NYSE: COO) reported Q4 EPS of $1.95, $0.08 worse than the analyst estimate of $2.03. Revenue for the quarter came in at $468 million versus the consensus estimate of $481.6 million.

Cooper Cos. sees FY2014 EPS of $7.30-$7.70, versus prior guidance of $8.2-$8.6 and the consensus of $8.24.

Commenting on the results, Robert S. Weiss, Cooper's president and chief executive officer said, "I am pleased to report record revenue this year at both our business units and record non-GAAP EPS. We accomplished this through continued market share gains across all geographies and the acquisition of Sauflon Pharmaceuticals. Our business fundamentals remain strong and we expect fiscal 2015 to be a year of strong operational performance."

For earnings history and earnings-related data on Cooper Cos. (COO) click here.